Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.
about
Anticoagulation for people with cancer and central venous cathetersAnticoagulation for patients with cancer and central venous cathetersAnticoagulation for patients with cancer and central venous cathetersAnticoagulation for thrombosis prophylaxis in cancer patients with central venous cathetersVentricular metastasis resulting in disseminated intravascular coagulationThe effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trialsThe effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trialsTrousseau's syndrome: multiple definitions and multiple mechanismsCardiopulmonary bypass in patients with pre-existing coagulopathySafety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature.Ischemic Heart Disease: Special Considerations in Cardio-Oncology.Implanting totally implantable venous access port via the internal jugular vein guided by ultrasonography is feasible and safe in patients with breast cancer.Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.Multiple extra-ischemic hemorrhages following intravenous thrombolysis in a patient with Trousseau syndrome: case study.Combined pulmonary venous thromboembolism and renal artery thrombosis in a patient with non-small cell lung cancerA case of Trousseau syndrome caused by pulmonary adenocarcinoma that was controlled for one year and 10 months with thrombosis treatment using an EGFR tyrosine kinase inhibitor and chemotherapy.Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients.Cerebral infarction in advanced non-small cell lung cancer: a case control study.Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices: a meta-analysis of comparative studies.Prevalence of upper extremity deep venous thrombosis diagnosed by color Doppler duplex sonography in cancer patients with central venous catheters.Increased risk of venous thromboembolism in patients with acute leukaemia.Thrombosis and acute lymphoblastic leukaemia.Application and comparison of different implanted ports in malignant tumor patientsIdentification of patient venous thromboembolism risk across the continuum of care.Management of thrombotic complications in acute lymphoblastic leukemia.New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients.Comparison of three types of central venous catheters in patients with malignant tumor receiving chemotherapy.The Successful Removal of Two Retrievable Inferior Vena Cava (IVC) Filters after 67 Days in a Patient with a Double IVCAcute disseminated intravascular coagulation in neuroendocrine carcinoma.Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.Cardiac metastasis of squamous cell carcinoma of the thyroid gland with severe disseminated intravascular coagulation: A case report.Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia PatientsPredictors of survival for patients with cancer after cryptogenic stroke.Administration of chemotherapy by an arteriovenous fistula in a patient with metastatic rectal cancer after life-threatening, port thrombosis-associated cava superior syndrome. An option for patients without possibility of peripheral or central venoA pediatric patient with a mediastinal mass and pulmonary embolus.Upper-Extremity Deep Vein Thrombosis in Patients With Breast Cancer With Chest Versus Arm Central Venous Port Catheters.Association of Peripheral Monocyte Count with Soluble P-Selectin and Advanced Stages in Nasopharyngeal Carcinoma.Thrombosis and cancer
P2860
Q24193103-E994539D-8E70-4EE2-AC4D-E5264028CA9DQ24235260-002EB75B-8B94-45B1-A453-0E5A1C99A846Q24236648-C96232E0-63A9-4D34-85F5-9A90D308DDBEQ24244042-90C14622-C320-4591-A9E6-0CACBA3A2A6EQ24811669-38E473B2-1508-4D2D-AC90-EB13487AE536Q26852293-3E2508E2-EC1A-49DA-87CD-F0AD4D7A113EQ28296482-AFAE23C0-02BF-4CA6-8B06-DB1FF0B92847Q28301882-2CC4478B-3FE5-4593-8F3B-40B32B3F314EQ33365668-A52119A7-1562-4A8C-B1B0-FEBC249764D9Q33365781-45C4DE72-F390-455D-B7BB-B606748A1346Q33441165-066EC55A-968C-4513-BC2B-77B66F55807FQ34695723-189C81FF-6837-4EB5-9AF4-4D79D2F0346AQ35048404-8895E1C1-A66F-439E-B671-EB56A84F328DQ35220883-7B1CAFFA-D693-441A-B1CB-FAB80FD93F3EQ35227708-4FC6A995-527A-4108-A88D-6242C75DB4EBQ35849625-35564EBE-D367-4B36-A096-A9AF3FA6F48AQ35949243-B27DCB84-6A5E-4C93-B073-536CA1FCDA05Q35953100-4DDCA87F-A6CB-4BB2-8D15-E9BAFCFCA54DQ36141727-A2DAF2C1-3F51-429A-802C-FC9C5314BC72Q36602368-5A632144-6AA7-48B5-B0F5-E1D5325F82D4Q36613611-A7DBDF4E-48E7-40B6-8BE1-FA795A6F6D77Q36869374-2CAEA490-082F-449F-9DFC-9D0A0D1057BBQ37280732-77225729-7A23-407E-831C-005C72AF0173Q37877058-EF304B57-EE00-4591-BBEF-F53D13767077Q38126391-C4011086-2162-4C00-B101-064A73A1162DQ38223377-2404FF26-491C-4B74-8342-1FD2ED60D950Q41037426-F6F15670-2374-46D6-A596-D459A81B7059Q41073975-804C14CB-F26E-4C59-A54E-4F3987A5D489Q41351602-7ECEBC73-1B95-4726-BC14-3F16BF26B2CDQ42007941-F5A16B1F-D9A4-439F-97BC-DCFFA9F48D8FQ42095099-E751F4D8-20E2-43CC-AFE7-8821E89C7BB2Q42352047-D0B96351-1E51-4E95-B63B-4D8F2015CFE3Q48840907-5727970A-4546-4EEC-BC88-E90DB7FA2E2DQ51321613-2E59C25A-E2F2-4352-96E0-4B1F2251FC42Q53542531-7116D7A4-E1BD-4D63-8ECF-8A30FF8F7169Q55223017-330DCEEF-2487-4E8F-8C48-720D0849CB4EQ55255652-BED6B23E-6D6F-4A70-A179-ACEA5FC0DCD3Q56339353-3D8CB868-ECC8-45B8-AFF0-489827DF5AF0
P2860
Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Thromboembolic complications o ...... sis, diagnosis, and treatment.
@ast
Thromboembolic complications o ...... sis, diagnosis, and treatment.
@en
type
label
Thromboembolic complications o ...... sis, diagnosis, and treatment.
@ast
Thromboembolic complications o ...... sis, diagnosis, and treatment.
@en
prefLabel
Thromboembolic complications o ...... sis, diagnosis, and treatment.
@ast
Thromboembolic complications o ...... sis, diagnosis, and treatment.
@en
P2093
P356
P1476
Thromboembolic complications o ...... sis, diagnosis, and treatment.
@en
P2093
Douglas E Sutherland
Howard A Liebman
Ilene C Weitz
P2860
P356
10.1002/AJH.10263
P577
2003-01-01T00:00:00Z